1. Home
  2. INDB vs ARQT Comparison

INDB vs ARQT Comparison

Compare INDB & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Independent Bank Corp.

INDB

Independent Bank Corp.

HOLD

Current Price

$78.38

Market Cap

3.8B

Sector

Finance

ML Signal

HOLD

Logo Arcutis Biotherapeutics Inc.

ARQT

Arcutis Biotherapeutics Inc.

HOLD

Current Price

$21.04

Market Cap

3.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INDB
ARQT
Founded
1907
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.8B
3.3B
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
INDB
ARQT
Price
$78.38
$21.04
Analyst Decision
Hold
Strong Buy
Analyst Count
4
6
Target Price
$87.00
$34.00
AVG Volume (30 Days)
318.0K
1.2M
Earning Date
04-16-2026
05-06-2026
Dividend Yield
3.32%
N/A
EPS Growth
N/A
88.79
EPS
1.63
N/A
Revenue
N/A
$376,072,000.00
Revenue This Year
$33.83
$34.85
Revenue Next Year
$5.85
$29.39
P/E Ratio
$48.00
N/A
Revenue Growth
N/A
91.34
52 Week Low
$59.61
$12.72
52 Week High
$87.00
$31.77

Technical Indicators

Market Signals
Indicator
INDB
ARQT
Relative Strength Index (RSI) 52.90 34.05
Support Level $76.77 $19.60
Resistance Level $81.80 $21.84
Average True Range (ATR) 1.54 1.15
MACD -0.01 -0.25
Stochastic Oscillator 64.76 15.69

Price Performance

Historical Comparison
INDB
ARQT

About INDB Independent Bank Corp.

Independent Bank Corp is a bank holding company and the sole shareholder of its bank, the Rockland Trust Company. Rockland is a community-oriented commercial bank. The bank provides a variety of banking, investment and financial services, operating with various retail branches, as well as a network of commercial and residential lending centers and investment management offices majorly in Eastern Massachusetts, Worcester County, and Rhode Island. The bank's loan portfolio constitutes the bulk of the bank's total assets. Its borrowers consist mostly of small to medium-size businesses and consumers, majority of which are made to its market area in eastern Massachusetts and Rhode Island. The bank's loan portfolio is predominantly in commercial loans.

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. Its current portfolio is comprised of differentiated topical and systemic treatments with potential to treat immune-mediated dermatological diseases and conditions. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. The Company has one reportable segment relating to the development and commercialization of treatments for dermatological diseases.

Share on Social Networks: